NovoLog (Dispensing Solutions, Inc.)


Welcome to the PulseAid listing for the NovoLog drug offered from Dispensing Solutions, Inc.. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dispensing Solutions, Inc.
NON-PROPRIETARY NAME: insulin aspart
SUBSTANCE NAME: INSULIN ASPART
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Insulin [Chemical/Ingredient],Insulin Analog [EPC]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-01-22
END MARKETING DATE: 0000-00-00


NovoLog HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNovoLog from Dispensing Solutions, Inc.
LABELER NAME: Dispensing Solutions, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100([iU]/mL)
START MARKETING DATE: 2003-01-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68258-8899_5d8213bc-800b-4e52-af9e-3ba3e5f2650c
PRODUCT NDC: 68258-8899
APPLICATION NUMBER: NDA020986

Other INSULIN ASPART Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions, Inc.NovoLog
Novo NordiskFiasp
Physicians Total Care, Inc.NovoLog Mix 70/30
TYA PharmaceuticalsNovoLog